Top compounds associated with response to DLST


Feature Type Standardized
Nominal ANOVA
mRNA LFM-A13 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA lomeguatrib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Doxorubicin FIMM pan-cancer AAC 0.056 0.7
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA momelotinib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC 0.027 0.7
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.012 0.7
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.012 0.7
Download CSV